Cargando…
Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment
Type 2 diabetes mellitus (T2DM) is a leading risk factor for cardiovascular complications around the globe and one of the most common medical conditions. Atrial fibrillation (AF) is the most common supraventricular arrhythmia, with a rapidly increasing prevalence. T2DM has been closely associated wi...
Autores principales: | Leopoulou, Marianna, Theofilis, Panagiotis, Kordalis, Athanasios, Papageorgiou, Nikolaos, Sagris, Marios, Oikonomou, Evangelos, Tousoulis, Dimitris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236990/ https://www.ncbi.nlm.nih.gov/pubmed/37273256 http://dx.doi.org/10.4239/wjd.v14.i5.512 |
Ejemplares similares
-
Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics
por: Sagris, Marios, et al.
Publicado: (2021) -
Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
por: Theofilis, Panagiotis, et al.
Publicado: (2023) -
Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
por: Theofilis, Panagiotis, et al.
Publicado: (2021) -
Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
por: Sagris, Marios, et al.
Publicado: (2022) -
Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches
por: Theofilis, Panagiotis, et al.
Publicado: (2022)